23 /100
LOW RISK
Score updated May 28, 2026

TNGX — Tango Therapeutics, Inc. Dilution Risk Tracker

Track TNGX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNGX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TNGX.
🔔 Track TNGX — Get forecast alerts →

💹 Market Data

Market Cap$2.88B
Shares Outstanding144.65M
Float69.60M
Cash$379.84M
Debt$32.79M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 51.6% shares (2025Q4 vs prior)
170 institutional holders · 214.04M shares
#1 Boxer Capital Management, LLC 40.80M shares
#2 FARALLON CAPITAL MANAGEMENT LLC 23.82M shares
#3 TCG Crossover Management, LLC 12.76M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest38.25M
Days to Cover12.5
% of Float55.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Jun 30, 2021
4 INSIDER TRANSACTION Feb 27, 2026
4 INSIDER TRANSACTION Feb 04, 2026
4 INSIDER TRANSACTION Feb 04, 2026
4 INSIDER TRANSACTION Feb 04, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track TNGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TNGX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for TNGX
📊 TNGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TNGX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.